Zenotech Laboratories38.80
+0.65 (+0.52%)

Zenotech Laboratories Share Price

38.80+0.65 (+0.52%)
-20.31% past 1 Year

Corporate filings & documents

Announcements

Publication of extract of Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30 2026 in newspapers.
3 weeks ago
Publication of extract of Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30 2026 in newspapers.
3 weeks ago
Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Submission of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Approval for Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026.
3 weeks ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter and half year ended September 30 2026.
1 month ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter and half year ended September 30 2026.
1 month ago
Compliance under Regulation 74(5) of SEBI (DP) Regulations 2018.
1 month ago
Compliance under Regulation 74(5) of SEBI (DP) Regulations 2018.
1 month ago
Intimation of Closure of Trading Window
1 month ago
Intimation of Closure of Trading Window
1 month ago
Voting Results and Scrutinizer Report of 37th Annual General Meeting of the Company held on September 25 2026.
1 month ago
Voting Results and Scrutinizer Report of 37th Annual General Meeting of the Company held on September 25 2026.
1 month ago
Outcome of the 37th Annual General Meeting of the Company held on Friday September 25 2026.
1 month ago
Outcome of the 37th Annual General Meeting of the Company held on Friday September 25 2026.
1 month ago
Newspaper publication informing about 37th Annual General Meeting & e-Voting.
2 months ago
Newspaper publication informing about 37th Annual General Meeting & e-Voting.
2 months ago
Notice of 37th Annual General Meeting along with Annual Report for the FY 2025-26
2 months ago
Notice of 37th Annual General Meeting along with Annual Report for the FY 2025-26
2 months ago
Annual Report 2025-26 and the Notice of 37th Annual General Meeting
2 months ago
Annual Report 2025-26 and the Notice of 37th Annual General Meeting
2 months ago
Newspaper Advertisement
3 months ago
Newspaper Advertisement
3 months ago
Intimation of 37th Annual General Meeting of the Company to be held on Friday September 25 2026 at 10:30 a.m. IST through Video Conferencing mode.
3 months ago
Intimation of 37th Annual General Meeting of the Company to be held on Friday September 25 2026 at 10:30 a.m. IST through Video Conferencing mode.
3 months ago
Publication of extract of Unaudited Financial Results for the quarter ended June 30 2026 in newspapers.
3 months ago
Publication of extract of Unaudited Financial Results for the quarter ended June 30 2026 in newspapers.
3 months ago
Outcome of the Board Meeting held today i.e. July 28 2026
3 months ago
Outcome of the Board Meeting held today i.e. July 28 2026
3 months ago
Submission of Unaudited Financial Results of the Company for the quarter ended June 30 2026.
3 months ago
Submission of Unaudited Financial Results of the Company for the quarter ended June 30 2026.
3 months ago
Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
4 months ago
Submission of Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026.
4 months ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter ended June 30 2026.
4 months ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve Unaudited Standalone Financial Results for the quarter ended June 30 2026.
4 months ago
Closure of Trading Window
4 months ago
Closure of Trading Window
4 months ago
Submission of Annual Secretarial Compliance Report for the financial year 2025-26
5 months ago
Copies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026 as published in todays newspaper i.e. April 30 2026.
6 months ago
Copies of extract of Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31 2026 as published in todays newspaper i.e. April 30 2026.
6 months ago
Audited Standalone Financial Results for the quarter and financial year ended March 31 2026 and declaration of unmodified opinion on the Financial Results.
6 months ago
Submission of Audited Standalone Financial Results for the quarter and financial year ended March 31 2026
6 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Zenotech Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L27100TG1989PLC010122</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>Nil</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Abdul Gafoor Mohammad <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Poly KV <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 28/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
6 months ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 inter alia to consider and approve Audited Standalone Financial Results for the quarter and financial year ended March 31 2026.
7 months ago
Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 inter alia to consider and approve Audited Standalone Financial Results for the quarter and financial year ended March 31 2026.
7 months ago

Concalls & investor presentations

Empty box

No presentations found

Zenotech Laboratories Ltd Share Price Today

The Zenotech Laboratories Ltd share price today is ₹41.75. During the trading session, the Zenotech Laboratories Ltd share price opened at ₹41.83 and recorded an intraday high of ₹42.15 and a low of ₹41.1. Last closing price was ₹41.83. Over the past 52 weeks, the Zenotech Laboratories Ltd share price has ranged between ₹33.55 and ₹54.14. The current Zenotech Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.